Plasma Exchange in Multiple Myeloma

  1. William F. Clark, MD
  1. From London Health Sciences Centre, London, Ontario N6A 4G5, Canada.

    IN RESPONSE:

    My coauthors and I concur that, on closer observation of our data, more questions are found than answers. We hope that most careful readers would experience this phenomenon when looking closely at data from other randomized, controlled trials. Dr. Leung raises the issue of an absence of renal biopsies and refers to an autopsy study published in 1990 (1), which indicated that 37% of patients with myeloma had light-chain or cast …

    « Previous | Next Article »Table of Contents